Purdue Pharma LP
- Country
- ๐บ๐ธUnited States
- Ownership
- Private
- Established
- 1892-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.purduepharma.com
The Effect of Buprenorphine Delivered by Buprenorphine Transdermal System (BTDS) at Doses up to 80 Micrograms/Hour (mcg/hr) and Naltrexone on Electrocardiogram (ECG) Intervals in Healthy Volunteers
- First Posted Date
- 2013-12-03
- Last Posted Date
- 2018-11-05
- Lead Sponsor
- Purdue Pharma LP
- Target Recruit Count
- 328
- Registration Number
- NCT01999114
- Locations
- ๐บ๐ธ
PPD Phase I Clinic, Austin, Texas, United States
An Analgesic Study to of V117957 for the Treatment of Postsurgical Pain Due to Third Molar Extraction
- Conditions
- Interventions
- First Posted Date
- 2013-07-16
- Last Posted Date
- 2013-12-05
- Lead Sponsor
- Purdue Pharma LP
- Target Recruit Count
- 114
- Registration Number
- NCT01900795
- Locations
- ๐บ๐ธ
PPD Dental Pain Clinic, Austin, Texas, United States
Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis (OA) of the Knee
- Conditions
- Interventions
- First Posted Date
- 2012-09-20
- Last Posted Date
- 2013-12-05
- Lead Sponsor
- Purdue Pharma LP
- Target Recruit Count
- 230
- Registration Number
- NCT01688934
- Locations
- ๐บ๐ธ
Jacksonville Center for Clinical Research, Jacksonville, Florida, United States
๐บ๐ธAvail Clinical Research, LLC, Deland, Florida, United States
๐บ๐ธWestside Center for Clinical Research, Jacksonville, Florida, United States
Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)
- Conditions
- Interventions
- First Posted Date
- 2012-09-20
- Last Posted Date
- 2014-05-12
- Lead Sponsor
- Purdue Pharma LP
- Target Recruit Count
- 105
- Registration Number
- NCT01688947
- Locations
- ๐บ๐ธ
Investigational Site, Salt Lake City, Utah, United States
Efficacy and Safety of Hydrocodone Bitartrate (HYD) in Subjects With Moderate to Severe Chronic Low Back Pain
- Conditions
- Interventions
- First Posted Date
- 2011-10-17
- Last Posted Date
- 2020-03-10
- Lead Sponsor
- Purdue Pharma LP
- Target Recruit Count
- 905
- Registration Number
- NCT01452529
- Locations
- ๐บ๐ธ
Coastal Clinical Research, Inc., Mobile, Alabama, United States
๐บ๐ธMeridien Research, Bradenton, Florida, United States
๐บ๐ธGold Coast Research, LLC, Plantation, Florida, United States
A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain
- Conditions
- Interventions
- First Posted Date
- 2011-09-01
- Last Posted Date
- 2015-02-12
- Lead Sponsor
- Purdue Pharma LP
- Target Recruit Count
- 450
- Registration Number
- NCT01427283
- Locations
- ๐บ๐ธ
Investigational Site, Bothell, Washington, United States
Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain
- Conditions
- Interventions
- First Posted Date
- 2011-09-01
- Last Posted Date
- 2014-11-07
- Lead Sponsor
- Purdue Pharma LP
- Target Recruit Count
- 455
- Registration Number
- NCT01427270
- Locations
- ๐ต๐ฑ
Investigational Site, Torun, Poland
Long-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain. Includes a 24-week Extension Period.
- Conditions
- Interventions
- First Posted Date
- 2011-07-22
- Last Posted Date
- 2020-03-10
- Lead Sponsor
- Purdue Pharma LP
- Target Recruit Count
- 922
- Registration Number
- NCT01400139
- Locations
- ๐บ๐ธ
Bone Joint and Spine Surgeons, Inc., Toledo, Ohio, United States
๐บ๐ธResearch Across America, New York, New York, United States
๐บ๐ธUpstate Clinical Research Associates, Williamsville, New York, United States
Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children Who Completed OTR3001
- First Posted Date
- 2011-06-09
- Last Posted Date
- 2015-09-09
- Lead Sponsor
- Purdue Pharma LP
- Target Recruit Count
- 23
- Registration Number
- NCT01369615
- Locations
- ๐บ๐ธ
Children's Hospital of Alabama, Birmingham, Alabama, United States
๐บ๐ธBayview Research Group, LLC, Paramount, California, United States
๐บ๐ธMercy Clinic Children's Cancer and Hematology Center, St. Louis, Missouri, United States
Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain
- Conditions
- Interventions
- First Posted Date
- 2011-05-23
- Last Posted Date
- 2015-11-11
- Lead Sponsor
- Purdue Pharma LP
- Target Recruit Count
- 1095
- Registration Number
- NCT01358526
- Locations
- ๐บ๐ธ
South Orange County Surgical Medical Group, Laguna Hills, California, United States
๐บ๐ธProbe Clinical Research Corporation, Santa Ana, California, United States
๐บ๐ธInnovative Research of West Florida, Inc., Clearwater, Florida, United States